KERLEDEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kerledex, and what generic alternatives are available?
Kerledex is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in KERLEDEX is betaxolol hydrochloride; chlorthalidone. There are eleven drug master file entries for this compound. Additional details are available on the betaxolol hydrochloride; chlorthalidone profile page.
Summary for KERLEDEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 88 |
Patent Applications: | 4,217 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KERLEDEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KERLEDEX
US Patents and Regulatory Information for KERLEDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-001 | Oct 30, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-002 | Oct 30, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KERLEDEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-002 | Oct 30, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-001 | Oct 30, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-002 | Oct 30, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-001 | Oct 30, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for KERLEDEX
See the table below for patents covering KERLEDEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 145119 | ⤷ Try a Trial | |
Spain | 452920 | ⤷ Try a Trial | |
New Zealand | 182498 | PHENOL ETHERS AND PHARMACEUTICAL COMPOSITIONS | ⤷ Try a Trial |
Belgium | 847801 | ⤷ Try a Trial | |
Australia | 1925976 | ⤷ Try a Trial | |
Finland | 62829 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |